Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 93
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 72
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
Mehrdad Hashemi, Motahare Sadat Ayat Mirdamadi, Yasmin Talebi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106568-106568
Open Access | Times Cited: 69
Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 58
Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance
Zhenli Guo, Milad Ashrafizadeh, Wei Zhang, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 29-53
Closed Access | Times Cited: 46
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 15
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 53
Long Noncoding RNA URB1-Antisense RNA 1 (AS1) Suppresses Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving Ferritin Phase Separation
Yuan Gao, Man Tong, Tin Lok Wong, et al.
ACS Nano (2023) Vol. 17, Iss. 22, pp. 22240-22258
Closed Access | Times Cited: 36
A comprehensive review on the emerging role of long non-coding RNAs in the regulation of NF-κB signaling in inflammatory lung diseases
Asif Ahmad Bhat, Obaid Afzal, Neetu Agrawal, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126951-126951
Closed Access | Times Cited: 35
FGFR families: biological functions and therapeutic interventions in tumors
Qing Liu, Jiyu Huang, Weiwei Yan, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 35
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114168-114168
Open Access | Times Cited: 28
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research (2023) Vol. 233, pp. 116458-116458
Closed Access | Times Cited: 23
Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance
Dexin Xu, Wenhai Wang, Duo Wang, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 388-406
Open Access | Times Cited: 12
Connecting the Dots: LncRNAs in the KRAS Pathway and Cancer
Mudasir Maqbool, Md Sadique Hussain, Ajay Singh Bisht, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155570-155570
Closed Access | Times Cited: 10
Discovery of a Potent Dual Son of Sevenless 1 (SOS1) and Epidermal Growth Factor Receptor (EGFR) Inhibitor for the Treatment of Prostate Cancer
Lufeng Zheng, Yuxin Zhang, Shuang Mei, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7130-7145
Closed Access | Times Cited: 9
Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms
Yue Shi, Joseph Adu‐Amankwaah, Qizhong Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27207-e27207
Open Access | Times Cited: 8
Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs
Farhad Sheikhnia, Ahmad Fazilat, Vahid Rashidi, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155374-155374
Closed Access | Times Cited: 8
Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah, et al.
Environmental Research (2023) Vol. 227, pp. 115683-115683
Closed Access | Times Cited: 17
FTO-stabilized miR-139–5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway
Baihetiya Azhati, Aerziguli Reheman, Diliyaer Dilixiati, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 741, pp. 109604-109604
Closed Access | Times Cited: 17
Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer
Mohammad Taheri, Elham Badrlou, Bashdar Mahmud Hussen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Androgen‐repressed lncRNA LINC01126 drives castration‐resistant prostate cancer by regulating the switch between O‐GlcNAcylation and phosphorylation of androgen receptor
Yi Cai, Minfeng Chen, Yuchen Gong, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Non-Coding RNA: A Key Regulator in the Glutathione-GPX4 Pathway of Ferroptosis
Md Sadique Hussain, Gaurav Gupta, Moyad Shahwan, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1222-1234
Open Access | Times Cited: 6
Plasma extracellular vesicles microRNA-208b-3p and microRNA-143-3p as novel biomarkers for sudden cardiac death prediction in acute coronary syndrome
Shuainan Huang, Jiahui Zhang, Hua Wan, et al.
Molecular Omics (2023) Vol. 19, Iss. 3, pp. 262-273
Closed Access | Times Cited: 14
Prediction of lncRNA and disease associations based on residual graph convolutional networks with attention mechanism
Sheng‐Chang Wang, Jiaqing Qiao, Shou Feng
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Advancements in long non-coding RNA-based therapies for cancer: targeting, delivery, and clinical implications
Muhammad Ammad, Zeeshan Javed, Haleema Sadia, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top